This article has not been reviewed, approved, endorsed, or sponsored by any of the trademark holders listed above
The SELECT trial showed that semaglutide 2.4 mg (Wegovy) reduces cardiovascular risk in adults with established cardiovascular disease and either overweight or obesity, leading to an FDA-approved indication for reducing cardiovascular risk in this population
[15] It is important to note that there is no official link confirmed between Mounjaro and menstrual spotting in regulatory documentation, and any changes should be evaluated individually
It interferes with the skins natural pigmentation process, making the complexion appear fairer and more even-toned
This process is especially important during physical activity, helping to increase endurance and support fat utilization as a fuel source
repression of redox transcription factors are also included in the evaluation of antioxidant activity at the cellular level [15]